Rationalizing Pharmaceutical Spending

Rationalizing Pharmaceutical Spending
READ MORE...
Volume/Issue: Volume 2022 Issue 190
Publication date: September 2022
ISBN: 9798400219849
$20.00
Add to Cart by clicking price of the language and format you'd like to purchase
Available Languages and Formats
paperback else
pdf else
epub else
English
Prices in red indicate formats that are not yet available but are forthcoming.
Topics covered in this book

This title contains information about the following subjects. Click on a subject if you would like to see other titles with the same subjects.

Economics- Macroeconomics , Public Finance , Economics / General , Health Policy , Pharmaceutical spending , pharmaceutical policy , generics , biosimilar , procurement , economic evaluation , volume share , percentage value share , share of generic , efficiency gain , Health care , Health care spending , Consumption , Global , Europe

Summary

Pharmaceutical spending accounts for a large share of health spending worldwide. While pharmaceuticals are an indispensable component of effective modern health systems, and their benefits in terms of increasing life expectancy and improving quality of life are unquestionable, the large variation in pharmaceutical spending across countries suggests that there may be large efficiency gains to be realized. This paper reviews the existing literature and databases on the level and composition of pharmaceutical spending and estimates potential efficiency gains from increased use of generics. It also reviews how countries organize the procurement and tendering of pharmaceuticals and the implications for spending. Finally, the paper identifies the various channels through which spending inefficiencies can arise and identifies reform options for reducing pharmaceutical spending while ensuring quality health outcomes.